Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Journal of Virology|May 28, 2004
Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasionMichael D Bobardt, Patrick Salmon, Lianchun Wang, et al.
Scientific Reports|March 15, 2022
Robo4 is constitutively shed by ADAMs from endothelial cells and the shed Robo4 functions to inhibit Slit3-induced angiogenesisWenyuan Xiao, Alejandro Pinilla-Baquero, John Faulkner, et al.
Viruses|March 26, 2022
Developing an Effective Peptide-Based Vaccine for COVID-19: Preliminary Studies in Mice ModelsHaiqiang Yang, Jessica Cao, Xiaoyang Lin, et al.
ACS Nano|May 9, 2014
Tumor vasculature targeted photodynamic therapy for enhanced delivery of nanoparticlesZipeng Zhen, Wei Tang, Yen-Jun Chuang, et al.
Carbohydrate Polymers|January 8, 2025
Characterization of heparin interactions with Clostridioides difficile toxins and its potential as anti-CDI therapeuticsFuming Zhang, Shaohui Wang, Jiyuan Yang, et al.
The Journal of Biological Chemistry|March 21, 2007
Selectin blocking activity of a fucosylated chondroitin sulfate glycosaminoglycan from sea cucumber. Effect on tumor metastasis and neutrophil recruitmentLubor Borsig, Lianchun Wang, Moises C M Cavalcante, et al.
Scientific Reports|August 9, 2018
Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-SulfotransferaseDavid F Thieker, Yongmei Xu, Digantkumar Chapla, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 14, 2018
Endothelial heparan sulfate deficiency reduces inflammation and fibrosis in murine diabetic nephropathyDitmer T Talsma, Kirankumar Katta, Marieke A B Ettema, et al.
Scientific Reports|June 10, 2020
Author Correction: Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-SulfotransferaseDavid F Thieker, Yongmei Xu, Digantkumar Chapla, et al.
Pageof 13